Estonia vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Estonia
100.0%
in 2024
Sur
82.0%
in 2024
Estonia rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Estonia
- Sur
How they compare
Estonia currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Estonia's figure about 1.2 times Sur's.
The two have swapped places 6 times across 17 shared years of data; in 2008 it was Estonia ahead.
Estonia ranks 1st and Sur ranks 2nd of 144 countries.
Estonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Estonia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.5% | 41.0% | 4.5% | Estonia |
| 2010s | 76.8% | 66.3% | 10.5% | Estonia |
| 2020s | 93.2% | 75.8% | 17.4% | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Estonia or Sur?
- Estonia, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Estonia and Sur?
- 18.0%, with Estonia ahead.
- How many years of comparable data are there for Estonia and Sur?
- 17 years are reported by both, from 2008 to 2024.
- How do Estonia and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Estonia ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.